News

RTX's F135 Engine Achieves Milestone in Flight Hours

RTX's F135 Engine Achieves Milestone in Flight Hours

RTX's F135 Engine Reaches Over One Million Flight Hours

World's most advanced fighter engine continues to deliver on safety and readiness for global F-35 operators

Pratt & Whitney, an RTX (NYSE: RTX) business, has announced that the F135 engine has surpassed one million flight hours powering the F-35 Lightning II. This extraordinary milestone underscores the F135's reputation as the most capable, safest, and reliable fighter engine currently available, offering exceptional performance and cutting-edge low-observable technologies vital for fifth-generation aircraft.

"The F135 engine plays a critical role in maintaining global air superiority for the U.S. and its allies, as it enables the F-35 mission in even the most contested environments," said Jill Albertelli, president of Military Engines at Pratt & Whitney. This engine has powered every F-35 since its inception, displaying outstanding safety and readiness rates over nearly two decades. Achieving this significant accomplishment affirms the F-35's importance in modern defense operations and highlights Pratt & Whitney's dedication to supporting its customers and the warfighter.

The F135 engine represents a substantial leap in terms of performance and reliability, providing warfighters with the confidence that it is poised to meet the demands of various missions. It consistently exceeds full mission capability rate requirements of 94%, boasting an unparalleled safety record that is markedly superior compared to previous generations of fighter engines throughout their service life.

To sustain mission readiness, the F135 benefit from an extensive sustainment network that supports multiple global depot facilities, 36 bases, and 12 ships across international waters. This framework positions the F135 as a key enabler of Agile Combat Employment, a tactical military operational concept designed to enhance survivability while boosting combat power through a network of dispersed locations. This concept demands continuous logistical movement, efficiency, and specialized maintenance skills—all of which Pratt & Whitney can provide using the F135's global infrastructure.

As the F-35 undergoes modernization to incorporate new capabilities aimed at addressing emerging threats, expectations for the engine's performance will only increase. Pratt & Whitney's Engine Core Upgrade (ECU) aims to build upon the successful legacy of the F135 by integrating advanced technology insights from other engine programs. This upgrade promises the enhanced performance necessary to stay ahead of global adversaries.

Thus far, Pratt & Whitney has successfully delivered more than 1,300 F135 production engines to a collaborative network involving 20 allied nations worldwide. For further details regarding the F135 engine, please visit the Pratt & Whitney website.

About Pratt & Whitney
Pratt & Whitney is a global leader in designing, manufacturing, and servicing aircraft engines and auxiliary power units. To discover more about their offerings, visit www.prattwhitney.com.

About RTX
RTX employs more than 185,000 individuals globally and is at the forefront of technological advancements aimed at transforming how we connect and protect our world. Through its premier businesses—Collins Aerospace, Pratt & Whitney, and Raytheon—the company is enhancing aviation, engineering integrated defense systems, and developing next-generation technology solutions that address critical challenges faced by its global clientele. With more than $69 billion in sales, RTX operates from its headquarters in Arlington, Virginia.

Frequently Asked Questions

What is the significance of the F135 engine's one million flight hours?

The one million flight hours signify the F135 engine's reliability and capability in powering the F-35 fighter, establishing it as the safest and most efficient option available.

How does the F135 engine support military operations?

The F135 enables global air superiority by ensuring the F-35 can operate effectively in contested environments, providing operational readiness for military missions.

What upgrades are being implemented for the F135 engine?

The Engine Core Upgrade aims to enhance the F135's performance, incorporating advanced technologies to meet future operational needs and threats.

How does Pratt & Whitney ensure mission readiness for the F135?

Through an extensive sustainment network, Pratt & Whitney supports numerous facilities and bases globally, enhancing the F135's operational readiness and efficiency.

What countries use the F135 engine?

Over 20 allied nations around the world utilize the F135 engine, highlighting its global adoption and the trust placed in its capabilities by allied forces.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading